92 related articles for article (PubMed ID: 8758470)
1. [In vitro activity of a new fluoroquinolone, marbofloxacin (RO 09-1168) against strictly anaerobic bacteria and some bacteria from human fecal flora].
Dubreuil L; Houcke I; Leroy I
Pathol Biol (Paris); 1996 May; 44(5):333-6. PubMed ID: 8758470
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of E-4868, a new fluoroquinolone with a 7-azetidin ring, compared with ciprofloxacin, ofloxacin and fleroxacin.
Mirelis B; Navarro F; Miró E; Coll R; Xicota MA; Prats G
Drugs Exp Clin Res; 1995; 21(4):129-38. PubMed ID: 8529525
[TBL] [Abstract][Full Text] [Related]
3. [In vitro antibacterial activity of lomefloxacin, a new fluoroquinolone, against hospital strains. Results of a multicenter study].
Soussy CJ; Le Van Thoi J; Morel C; Acar JF; Thabaut A; Fleurette J; Vallée E; Dabernat H; Chanal M; Drugeon H
Pathol Biol (Paris); 1990 May; 38(5):390-6. PubMed ID: 2195448
[TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
Dubreuil L; Devos J; Romond C; Bryskier A
Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
[TBL] [Abstract][Full Text] [Related]
5. [Sensitivity of obligate anaerobes to ofloxacin, pefloxacin, enoxacin and norfloxacin].
Dubreuil L; Devos J; Romond C; Bryskier A
Pathol Biol (Paris); 1985 May; 33(5):421-5. PubMed ID: 3162143
[TBL] [Abstract][Full Text] [Related]
6. [Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria].
Dubreuil L; Derriennic M; Sedallian A
Pathol Biol (Paris); 1990 May; 38(5):343-6. PubMed ID: 2367150
[TBL] [Abstract][Full Text] [Related]
7. The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(7):431-4. PubMed ID: 3836865
[TBL] [Abstract][Full Text] [Related]
8. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin.
Fung-Tomc J; Minassian B; Kolek B; Washo T; Huczko E; Bonner D
J Antimicrob Chemother; 2000 Apr; 45(4):437-46. PubMed ID: 10747819
[TBL] [Abstract][Full Text] [Related]
9. Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria.
Edlund C; Sabouri S; Nord CE
Eur J Clin Microbiol Infect Dis; 1998 Mar; 17(3):193-5. PubMed ID: 9665302
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activities of ABT-773 against 362 clinical isolates of anaerobic bacteria.
Citron DM; Appleman MD
Antimicrob Agents Chemother; 2001 Jan; 45(1):345-8. PubMed ID: 11120995
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteria.
Wexler HM; Molitoris E; Reeves D; Finegold SM
J Antimicrob Chemother; 1994 Oct; 34(4):579-84. PubMed ID: 7868409
[TBL] [Abstract][Full Text] [Related]
12. Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria.
Goldstein EJ; Citron DM
Antimicrob Agents Chemother; 1992 May; 36(5):1158-62. PubMed ID: 1324640
[TBL] [Abstract][Full Text] [Related]
13. The frequency of in vitro resistance to fluoroquinolones among clinical isolates of Escherichia coli.
Poiată A; Bădicuţ I; Grigore L; Buiuc D
Roum Arch Microbiol Immunol; 2000; 59(1-2):63-9. PubMed ID: 11845477
[TBL] [Abstract][Full Text] [Related]
14. Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria.
MacGowan AP; Bowker KE; Holt HA; Wootton M; Reeves DS
J Antimicrob Chemother; 1997 Oct; 40(4):503-9. PubMed ID: 9372419
[TBL] [Abstract][Full Text] [Related]
15. In vitro susceptibility of anaerobes to quinolones in the United States.
Hecht DW; Wexler HM
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S2-8. PubMed ID: 8953099
[TBL] [Abstract][Full Text] [Related]
16. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.
Nord CE; Lindmark A; Persson I
Eur J Clin Microbiol Infect Dis; 1993 Aug; 12(8):640-2. PubMed ID: 8223667
[TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of temafloxacin against anaerobic bacteria: a comparative study.
Finegold SM; Molitoris E; Reeves D; Wexler HM
J Antimicrob Chemother; 1991 Dec; 28 Suppl C():25-30. PubMed ID: 1664827
[TBL] [Abstract][Full Text] [Related]
19. Comparison of faecal and optimal growth conditions on in vitro pharmacodynamic activity of marbofloxacin against Escherichia coli.
Pellet T; Gicquel-Bruneau M; Sanders P; Laurentie M
Res Vet Sci; 2006 Jun; 80(3):324-35. PubMed ID: 16126240
[TBL] [Abstract][Full Text] [Related]
20. Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.
Hecht DW; Osmolski JR
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S44-50. PubMed ID: 8953106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]